ATE216709T1 - Monoklonäler antikörper gegen die r2-untereinheit von ribonukleotid-reduktase - Google Patents

Monoklonäler antikörper gegen die r2-untereinheit von ribonukleotid-reduktase

Info

Publication number
ATE216709T1
ATE216709T1 AT96300819T AT96300819T ATE216709T1 AT E216709 T1 ATE216709 T1 AT E216709T1 AT 96300819 T AT96300819 T AT 96300819T AT 96300819 T AT96300819 T AT 96300819T AT E216709 T1 ATE216709 T1 AT E216709T1
Authority
AT
Austria
Prior art keywords
subunit
monoclonal antibody
ribonucleotide reductase
rnr
antibody against
Prior art date
Application number
AT96300819T
Other languages
English (en)
Inventor
Toshiaki Saeki
Toshiaki Kamei
Akiko Furuya
Nobuo Hanai
Takeshi Takahashi
Motoo Yamasaki
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE216709T1 publication Critical patent/ATE216709T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT96300819T 1995-02-07 1996-02-07 Monoklonäler antikörper gegen die r2-untereinheit von ribonukleotid-reduktase ATE216709T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1887995 1995-02-07

Publications (1)

Publication Number Publication Date
ATE216709T1 true ATE216709T1 (de) 2002-05-15

Family

ID=11983846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96300819T ATE216709T1 (de) 1995-02-07 1996-02-07 Monoklonäler antikörper gegen die r2-untereinheit von ribonukleotid-reduktase

Country Status (6)

Country Link
US (1) US5885830A (de)
EP (1) EP0726277B1 (de)
AT (1) ATE216709T1 (de)
CA (1) CA2169024A1 (de)
DE (1) DE69620814T2 (de)
ES (1) ES2173248T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2259123C (en) 1996-07-01 2003-10-21 Lorus Therapeutics Inc. Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
WO2000017225A2 (en) 1998-09-24 2000-03-30 The Trustees Of Columbia University In The City Of New York A small protein that interacts with a ribonucleotide reductase subunit and uses thereof
US6682917B1 (en) * 1999-06-28 2004-01-27 Takeda Chemical Industries, Ltd Protein having a ribonucleotide Reductase activity and a DNA thereof
CN1301816A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——核苷酸还原酶10和编码这种多肽的多核苷酸
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
EP2030615A3 (de) * 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen
WO2015123654A1 (en) 2014-02-17 2015-08-20 The Cleveland Clinic Foundation Amine passivated nanoparticles for cancer treatment and imaging

Also Published As

Publication number Publication date
CA2169024A1 (en) 1996-08-08
EP0726277A3 (de) 1997-01-15
ES2173248T3 (es) 2002-10-16
US5885830A (en) 1999-03-23
EP0726277B1 (de) 2002-04-24
DE69620814D1 (de) 2002-05-29
DE69620814T2 (de) 2002-12-12
EP0726277A2 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
FR2724182B1 (fr) Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
EP1042343A4 (de) Vegi, ein inhibitor der angiogenese und des tumorwachstums
DE68928857D1 (de) Monoklonale Antikörper, die mit Cachectin reagieren
EP1032268A4 (de) Reduzierte antigenzellen und ihre verwendung
CA2267072A1 (en) Reconstituted human anti-hm1.24 antibody
DE69838454D1 (de) Natürlicher menschlicher antikörper
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
BR0012195A (pt) Método para tratar câncer de próstata num ser humano, artigo de fabricação e uso de um anticorpo que liga erbb2
EP0643131A3 (de) Vorrichtung zum Sammeln und in-vitro-Transport von Proben, insbesondere für Diagnoseverwendungen.
ATE215380T1 (de) Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit
EP0667700A3 (de) Verfahren und Vorrichtung zur Echokompensation mit Anwendung der "fast projection scheme".
GB9503601D0 (en) Method of treatment and method of manufacture of medicament
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
EP0160250A3 (de) Monoklonale Antikörpersammlung zur Frühdiagnose und Behandlung von Nierenkarzinomen
MX9300550A (es) Estructura de fibra absorbente.
ATE216709T1 (de) Monoklonäler antikörper gegen die r2-untereinheit von ribonukleotid-reduktase
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
EP0707489A4 (de) Antigene spezifisch für atherosklerotischen belag, antikörper dafür, und verwendungen davon
FR2772509B1 (fr) Aiguille d'absorption de neutrons
DK0642341T3 (da) Anvendelse af inhibitorer af 3-hydroxy-3-methylglutaryl coenzym A reduktase som en kræftbehandlingsmåde
EP0759943A4 (de) Monoklonale antikörper spezifisch gegen vaskuläres endothelzellartigen endoglyx-1, das antigen selbst und seine verwendungen
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
AU657504B2 (en) Antibody against human plasmin-alpha2-plasmin inhibitor complex, hybridoma and immunoassay
ATE148922T1 (de) Monoklonale antikörper gegen glykolipid- karbohydratketten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties